• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAIII前列腺腺癌植入大鼠尾部后的转移扩散。

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat.

作者信息

Neubauer B L, Bemis K G, Best K L, Goode R L, Merriman R L, Smith G F, Tanzer L R, Hoover D M

出版信息

Prostate. 1986;8(3):265-76. doi: 10.1002/pros.2990080307.

DOI:10.1002/pros.2990080307
PMID:3703746
Abstract

The spontaneous metastatic spread of a suspension of PAIII prostatic adenocarcinoma cells from the tail site of implantation was analyzed over a period of 5 weeks in male Lobund-Wistar (LW) rats. Following subcutaneous injection of the PAIII cells, the tumor metastasized through the primary lymphatic drainage. PAIII microfoci were evident in the gluteal and iliac lymph nodes prior to colonization of the lungs. Growth of the primary tumor was evidenced by significant weight differences of the tails of PAIII-bearing and control rats 1 week after tumor implantation. Time-dependent sequential spread of the adenocarcinoma was quantitated. Significant differences were noted between PAIII-bearing and control animals with respect to the gluteal lymph node weights (+2 weeks), iliac lymph node weights (+3 weeks), dry lung weights, and lung colony numbers (+4 weeks) after tumor implantation. During the course of these studies, the whole blood prothrombin, activated partial thromboplastin, and recalcification times for the PAIII-bearing animals were similar to those of the control group. These findings indicate that there were no gross changes in systemic blood coagulation accompanying the metastasis of PAIII cells from the primary tumor. The tumor in LW rats produced a consistent pattern of growth and metastasis that is suitable for quantitation. The PAIII prostatic adenocarcinoma is a sensitive and reproducible system that may be useful to evaluate potential antimetastatic and cytotoxic agents for the treatment of hormone-insensitive prostatic cancer.

摘要

在雄性Lobund-Wistar(LW)大鼠中,对PAIII前列腺腺癌细胞悬液从植入尾部部位的自发转移扩散情况进行了为期5周的分析。皮下注射PAIII细胞后,肿瘤通过初级淋巴引流发生转移。在肺部定植之前,臀淋巴结和髂淋巴结中可见PAIII微病灶。肿瘤植入1周后,携带PAIII的大鼠和对照大鼠尾巴重量存在显著差异,证明了原发性肿瘤的生长。对腺癌的时间依赖性顺序扩散进行了定量分析。肿瘤植入后,在臀淋巴结重量(+2周)、髂淋巴结重量(+3周)、肺干重和肺集落数(+4周)方面,携带PAIII的动物和对照动物之间存在显著差异。在这些研究过程中,携带PAIII的动物的全血凝血酶原、活化部分凝血活酶和复钙时间与对照组相似。这些发现表明,PAIII细胞从原发性肿瘤转移时,全身血液凝固没有明显变化。LW大鼠中的肿瘤产生了一致的生长和转移模式,适合进行定量分析。PAIII前列腺腺癌是一个敏感且可重复的系统,可能有助于评估治疗激素不敏感型前列腺癌的潜在抗转移和细胞毒性药物。

相似文献

1
Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat.PAIII前列腺腺癌植入大鼠尾部后的转移扩散。
Prostate. 1986;8(3):265-76. doi: 10.1002/pros.2990080307.
2
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.雷洛昔芬(LY156758)在PAIII大鼠前列腺腺癌模型中产生抗转移反应并延长生存期。
Prostate. 1995 Oct;27(4):220-9. doi: 10.1002/pros.2990270407.
3
Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.新型二芳基磺酰脲类抗肿瘤药物LY181984对PAIII大鼠前列腺腺癌生长和转移的抑制作用
J Urol. 1992 Feb;147(2):500-4. doi: 10.1016/s0022-5347(17)37288-9.
4
Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.华法林对大鼠PAIII前列腺腺癌转移的抑制作用。
J Urol. 1986 Jan;135(1):163-6. doi: 10.1016/s0022-5347(17)45554-6.
5
Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.激素消融、雌激素激动剂、雌激素细胞毒性衍生物和抗雌激素在PAIII大鼠前列腺腺癌中的抗肿瘤效果比较
Cancer Res. 1992 Sep 1;52(17):4663-71.
6
The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.选择性雌激素受体调节剂三氧异黄酮(LY133314)在PAIII大鼠前列腺癌模型中可抑制转移并延长生存期。
Cancer Res. 2003 Sep 15;63(18):6056-62.
7
Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells.硒代昔布-1 的合成及其对大鼠前列腺腺癌细胞的抗肿瘤活性。
Int J Cancer. 2010 Jul 1;127(1):230-8. doi: 10.1002/ijc.25033.
8
Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.小肠黏膜下层不会促进Lobund-Wistar大鼠的PAIII肿瘤生长。
J Surg Res. 2004 Aug;120(2):189-94. doi: 10.1016/j.jss.2003.10.022.
9
PAIII prostate tumors express prostate specific antigen (PSA) in Lobund-Wistar rats.PAIII前列腺肿瘤在Lobund-Wistar大鼠中表达前列腺特异性抗原(PSA)。
Can J Vet Res. 2009 Jan;73(1):39-41.
10
Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats.在洛本德-威斯塔大鼠中使用活的组织因子缺陷细胞系进行前列腺癌疫苗接种。
Cancer Immunol Immunother. 2007 May;56(5):725-30. doi: 10.1007/s00262-006-0223-x. Epub 2006 Sep 5.

引用本文的文献

1
Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.药理剂量的抗坏血酸可抑制激素难治性前列腺癌的同种异体肿瘤生长和转移。
In Vivo. 2010 May-Jun;24(3):249-55.